domain | aignostics.com |
summary | More About us 19 AI healthtechs to watch, according to VCs Worlds Best Digital Health Companies 2024 10m samples with access to proprietary research cohorts 55m funding from blue-chip investors to date 2018 established in 2018, officially spun out in 2020 Our platform is GCP-ready clinical trial platform developed under: ISO 13485 certified QMS ISOIEC 27001 certified ISMS ISO 13485 certified QMS Careers Looking for an opportunity to work on something meaningful Be part of our diverse and fast-growing team and work on problems that really matter, while being embedded in an exciting mix of tech, scientific research and medical device development.Our openings In the news 29.10.2024 Aignostics secures 34M Series B to enhance precision medicine with AI 14.03.2024 Bayer and Aignostics to collaborate on next generation precision oncology 09.01.2024 Aignostics foundation model for histopathology takes the lead on key benchmarks 20.10.2023 Aignostics achieves ISO 13485 certification to support clinical research and diagnostics development 09.08.2022 Aignostics earns ISO 27001 certification for information security 09.03.2022 Aignostics Ultivue announce Unique Spatial AI-Powered Imaging Solutions for Translational Medicine 01.01.2022 We are appointing Jessica Riley as our new Chief Business Officer Read all news Cookie Policy Impressum Legal Notice Privacy Policy Copyright 2024 Aignostics GmbH All rights reserved. |
title | Aignostics - Turning complex biomedical data into transformative insights |
description | Aignostics turns complex biomedical data into transformative insights for biopharma companies through development of AI-powered precision medicine for pathology throughout the drug development pipeline from target identification, to translational research, and trials & companion diagnostics. |
keywords | |
upstreams |
women-in-data-ai.tech |
downstreams |
|
nslookup | A 75.2.70.75, A 99.83.190.102 |
created | 2024-12-01 |
updated | 2024-12-18 |
|
|